Skip to main content
. 2021 Jan 11;217(1):iyaa021. doi: 10.1093/genetics/iyaa021

Table 1.

 Summary of AI profiles identified across 33 tumor sites in TCGA

Tumor site TCGA abbreviation Number of samples Number of samples with AI Samples with AI (%) Genomic burden (median)
Adrenocortical carcinoma ACC 90 90 100.00 0.6326
Bladder urothelial carcinoma BLCA 411 408 99.27 0.5300
Breast invasive carcinoma BRCA 1101 1093 99.27 0.4366
Cervical squamous cell carcinoma and endocervical adenocarcinoma CESC 303 301 99.34 0.3444
Cholangiocarcinoma CHOL 36 34 94.44 0.3842
Colon adenocarcinoma COAD 462 455 98.48 0.3656
Lymphoid neoplasm diffuse large B-cell lymphoma DLBC 48 47 97.92 0.2011
Esophageal carcinoma ESCA 186 184 98.92 0.6446
Glioblastoma multiforme GBM 545 539 98.90 0.2088
Head and neck squamous cell carcinoma HNSC 527 526 99.81 0.4324
Kidney chromophobe KICH 66 64 96.97 0.4115
Kidney renal clear cell carcinoma KIRC 529 521 98.49 0.1731
Kidney renal papillary cell carcinoma KIRP 288 281 97.57 0.1996
Acute myeloid leukemia LAML 200 106 53.00 0.0014
Brain lower grade glioma LGG 527 517 98.10 0.1317
Liver hepatocellular carcinoma LIHC 377 369 97.88 0.3194
Lung adenocarcinoma LUAD 517 514 99.42 0.5539
Lung squamous cell carcinoma LUSC 502 495 98.61 0.5921
Mesothelioma MESO 87 85 97.70 0.2800
Ovarian serous cystadenocarcinoma OV 595 592 99.50 0.6202
Pancreatic adenocarcinoma PAAD 185 170 91.89 0.2627
Pheochromocytoma and paraganglioma PCPG 183 179 97.81 0.1543
Prostate adenocarcinoma PRAD 496 465 93.75 0.0910
Rectum adenocarcinoma READ 168 167 99.40 0.5100
Sarcoma SARC 261 253 96.93 0.4069
Skin cutaneous melanoma SKCM 472 469 99.36 0.4263
Stomach adenocarcinoma STAD 442 436 98.64 0.4303
Testicular germ cell tumors TGCT 156 156 100.00 0.6504
Thyroid carcinoma THCA 509 195 38.31 0.0000
Thymoma THYM 124 85 68.55 0.0263
Uterine corpus endometrial carcinoma UCEC 546 481 88.10 0.1174
Uterine carcinosarcoma UCS 55 55 100.00 0.5941
Uveal melanoma UVM 80 79 98.75 0.1628